Apricus Biosciences (APRI) Gains After Announcing Patent for Treating Raynaud's Disease
Tweet Send to a Friend
Apricus Biosciences, Inc. (Nasdaq: APRI) announced on January 27, 2015, the United States Patent and Trademark Office (USPTO) issued to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
